Literature DB >> 6771019

Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain.

J Rogers, P Early, C Carter, K Calame, M Bond, L Hood, R Wall.   

Abstract

During differentiation, B lymphocytes undergo a shift from expression of membrane-bound IgM to IgM secretion. The mu chains of membrane and secreted IgM, mum and mus, respectively, differ in the amino acid sequence of their carboxy terminal regions. In this paper, we demonstrate that mum and mus heavy chains are encoded by separate mRNAs of 2.7 and 2.4 kb, respectively. Restriction mapping and sequence analysis of mu cDNA clones from a myeloma tumor that produces both types of mu chain indicate that the mum and mus mRNAs are identical throughout the coding region up to the 3' end of the fourth constant region (Cmu 4) domain, but differ in their C terminal coding and 3' untranslated segments. From the nucleotide sequence of the mum cDNA clone, we predict the amino acid sequence of the 41-residue mum C terminal segment or "M" (membrane) segment. This sequence has characteristics consistent with its being a transmembrane peptide. Thus the mus chain has a 20-residue hydrophilic C terminal segment after the Cmu 4 domain, and the mum chain has a 41-residue C terminal segment containing a hydrophobic sequence. We propose that comparable C terminal segments also will be found in other membrane-bound immunoglobulin heavy chains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771019     DOI: 10.1016/0092-8674(80)90616-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  213 in total

1.  Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling.

Authors:  Y Yamanashi; Y Fukui; B Wongsasant; Y Kinoshita; Y Ichimori; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

2.  A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus.

Authors:  J M Liu; S W Green; T Shimada; N S Young
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Amino acids bracketing the predicted transmembrane domains of membrane proteins.

Authors:  C Pidgeon; R L Williard; S C Schroeder
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

4.  Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation.

Authors:  M C Raynal; Z Y Liu; T Hirano; L Mayer; T Kishimoto; S Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 5.  Targeting proteins to mitochondria: a current overview.

Authors:  L A Glover; J G Lindsay
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

6.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  Illegitimate recombination generates a class switch from C mu to C delta in an IgD-secreting plasmacytoma.

Authors:  A C Gilliam; A Shen; J E Richards; F R Blattner; J F Mushinski; P W Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

Review 8.  The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.

Authors:  J Tseng; Y J Lee; B J Eisfelder; M R Clark
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

9.  Expression of a human immunodeficiency virus type 1 long terminal repeat/simian virus 40 early region fusion gene in transgenic mice.

Authors:  J Skowronski
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Expression of an immunoglobulin heavy chain gene transfected into lymphocytes.

Authors:  R J Deans; K A Denis; A Taylor; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.